M. Impallomeni, F. Palusci, C. Petruzzi, E. Daneluzzo, D. Gianfelice, A. Rossi - Vol. 7, Dicembre 2001, num.4
Testo Immagini Bibliografia Summary Riassunto Indice
Disturbo di panico, qualità
della vita e assetto temperamentale in persone in trattamento con sertralina
Panic disorder, quality of life among people
with sertraline treatment
1 Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000;157:669-82.
2 Ruggeri M, Santolini N, Stegagno M, Imperadore G, Dall'Agnola RB. La qualità della vita come indicatore di esito. In: La Qualità di Vita dei Pazienti Psichiatrici. Tansella M, ed. Epidemiologia e Psichiatria Sociale. 1999;8:5-6.
3 Rapaport MH, Pollack M, Wolkow R, Mardekian J, Clary C. Is placebo response the same as drug response in panic disorder ? Am J Psychiatry 2000;157:1014-6.
4 Pohl RB, Wolkow RM, Clary CM. Sertraline in the treatment of panic disorder: a double-blind multicenter trial. Am J Psychiatry 1998;155:1189-95.
5 Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, et al., (Fluoxetine Panic Disorder Study Group). Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. Am J Psychiatry 1998;155:1570-7.
6 Ekselius L, von Knorring L. Changes in personality traits during treatment with sertraline or citalopram. Br J Psychiatry 1999;174:444-8.
7 Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998;155:373-9.
8 Spitzer RL, Williams JBW, Gibbon M, First MB. Intervista clinica strutturata per il DSM III R, (SCID-P, SCID-II), versione italiana. Firenze, OS Organizzazioni Speciali, 1993. (Original work published, American Psychiatric Press 1990).
9 Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025-36.
10 Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale: Preliminary report. In: Guy W, ed. ECDEU assessments manual for psychopharmacology. DHEW Publication No (ADM). Rockville: National Institute of Mental Health 1976:76-338.
11 Cloninger CR, Svrakic DM, Przybeck TR. The Tridimensional Personality Questionnaire: US normative data. Psychological Reports 1991;69:1047-57.
12 Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:573-88.
13 Katon W, Hollifield M, Chapman I, Mannuzza S, Ballenger J, Fyer A. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatry Res 1995;29:121-31.
14 Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996;153:213-8.
15 Fyer AJ, Katon W, Hollifield M, Rassnick H, Mannuzza S, Chapman T, et al. The DSM-IV panic disorder field trial: panic attack frequency and functional disability. Anxiety 1996;2:157-66.
16 Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry 1997;154:766-72.
17 Schonfeld WH, Verboncoeur CJ, Fifer SK, Lpschutz RC, Lubeck DP. The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Dis 1997;43:105-19.
18 Ettigi P, Meyerhoff AS, Chirban JT, Jacobs RJ, Wilson RR. The quality of life and employment in panic disorder. J Nerv Mental Dis 1997;185:368-72.
19 Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ III, Penava SJ, et al. Quality of life in patients with panic disorder. J Nerv Mental Dis 1999;187:429-34.
20 Jacobs RJ, Davidson JR, Gupta S, Meyerhoff AS. The effects of clonazepam on quality of life and work productivity in panic disorder. Ann J Man Care 1997;3:1187-96.
21 Mavissakalian MR, Perel JM, Talbott-Green M, Sloan C. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia. Biol Psychiatry 1998;43:848-54.
22 Impallomeni M, Roncone R, Casacchia M. Trattamento cognitivo-comportamentale di gruppo in persone con Disturbo di Panico con agorafobia: un'esperienza pilota. Studi di Psichiatria 2000;1:23-31.
23 Rossi A, Stratta P, Daneluzzo E, Spaziani D, Bustini M, Prosperini P. La quarta dimensione del Tridimensional Personality Disorder (TPQ): studio di validazione della versione italiana. Giorn It Psicopatol 1996; 3: 260-266.
24 Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50: 975-990.
25 Norusis MJ. SPSS for Windows. User's Guide. Release 5.0. SPSS. Chicago: Illinois 1993.
26 Battaglia M, Przybeck TR, Bellodi L, Cloninger CR. Temperament dimensions explain the comorbidity of psychiatric disorders. Compr Psychiatry 1996;37:292-8.
27 Ampollini P, Marchesi C, Signifredi R, Ghinaglia E, Scardovi F, Codeluppi S, et al. Temperament and personality features in patients with major depression, panic disorder and mixed conditions. J Affect Dis 1999;52:203-7.
28 Impallomeni M, Palusci F, Petruzzi C, Daneluzzo E, Rossi A. Variazioni nelle configurazioni temperamentali in soggetti con Disturbo di Panico trattati con sertralina. Giorn It Psicopat 2001;7:120-6.
29 Londborg PD, Wolkow R, Smith WT, DuBoff E, England D, Ferguson J, et al. Sertraline in the treatment of panic disorder. Br J Psychiatry 1998;173:54-60.
30 Pollack MH, Otto MW, Worthington JJ, Gus Manfro G, Wolkow R. Sertraline in the treatment of panic disorder. Arch Gen Psychiatry 1998;55:1010-6.
31 Ampollini P, Marchesi C, Signifredi R, Maggini C. Temperament and personality features in panic disorder with or without comorbid mood disorders. Acta Psychiatr Scand 1997;95:420-3.
32 Perna G, Bernaderschi L, Caldirola D, Garberi A, Draisci A, Battaglia M. Personality dimension in panic disorder: state versus trait issues. New Trends in Experimental and Clinical Psychiatry 1992;8:49-54.
33 Heym J. Pharmacology of sertraline: a review. J Clin Psychiatry 1998;49:40-5.
34 Lorenz S, Sederer LI. Assessing outcomes of psychiatric treatment. Direct Psychiatry 1998;18:129-47.